Pharmalink AB Receives Patent for Nefecon(R) Principle - SYS-CON Media (press release) PDF Print
SYS-CON Media (press release)... for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.